Summary & Overview
HCPCS J7500: Azathioprine, Oral, 50 mg
HCPCS Level II code J7500 denotes azathioprine, oral, 50 mg, an oral immunosuppressant used in autoimmune disease management and transplant medicine. This code matters nationally because it standardizes billing for a widely prescribed systemic medication with implications for pharmacy reimbursement, payer coverage policies, and outpatient medication management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for azathioprine use, typical sites of service for billing (outpatient pharmacy, clinic dispensing), and the practical billing considerations tied to HCPCS Level II coding. The publication outlines common modifiers associated with HCPCS drug administration and dispensing (listed separately), and summarizes how payers commonly approach coverage and prior authorization for oral immunosuppressants.
This resource provides benchmarks for billing practice, notes on policy updates affecting HCPCS Level II drug codes, and concise clinical context to help billing teams and policy analysts understand where J7500 fits into outpatient pharmacy workflows and payer coverage frameworks. Data not available in the input is identified explicitly where applicable.
Billing Code Overview
HCPCS Level II code J7500 represents azathioprine, oral, 50 mg, a systemic immunosuppressive medication used in the management of autoimmune conditions and for prevention of organ transplant rejection. The service type associated with this code is oral medication dispensing. The typical site of service for billing this code is outpatient pharmacy or clinic-administered oral medication dispensing.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with an autoimmune condition (for example, systemic lupus erythematosus, inflammatory bowel disease, or autoimmune hepatitis) or a solid-organ transplant recipient requiring chronic immunosuppression. The medication J7500 (Azathioprine, oral, 50 mg) is prescribed as a maintenance immunosuppressant or steroid-sparing agent. Clinical workflow: outpatient prescriber (rheumatologist, gastroenterologist, hepatologist, or transplant physician) documents diagnosis, reviews baseline labs (complete blood count, liver function tests, thiopurine methyltransferase activity when available), prescribes the appropriate oral dose in 50 mg tablets, and documents informed consent regarding potential adverse effects. The pharmacy dispenses and bills the medication, often using HCPCS J7500 for facility or payer reporting when oral azathioprine is billed under medical benefit; outpatient clinics administering and monitoring therapy capture associated visit and laboratory CPT codes. Follow-up visits assess efficacy and adverse events, with periodic laboratory monitoring and dose adjustments as clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | (Not a standard CMS modifier in common use for claims; placeholder) | Data not available in the input. |